Top compounds associated with response to STX5


Feature Type Standardized
Nominal ANOVA
mRNA JQ-1:vorinostat (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.078 0.02
mRNA nakiterpiosin CTRPv2 pan-cancer AAC -0.078 0.02
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC -0.07 0.02
mRNA thalidomide CTRPv2 pan-cancer AAC 0.13 0.02
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.08 0.03
mRNA Teniposide CTRPv2 pan-cancer AAC -0.09 0.03
mRNA Bexarotene CTRPv2 pan-cancer AAC -0.082 0.03
mRNA Sunitinib GDSC1000 pan-cancer AAC -0.12 0.03
mRNA SGC0946 GDSC1000 pan-cancer AAC -0.078 0.03
mRNA TPCA-1 CTRPv2 pan-cancer AAC -0.073 0.03
Download CSV